← Back to Search

Family Therapy for Cancer Palliative Care and Bereavement

N/A
Waitlist Available
Led By Talia Zaider, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For every enrolled family, there must be at least 2 family members willing/able to take part at the time of recruitment
Must not have
Age less than 12 years old for a child
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing how well family therapy works when given to families of seriously ill patients. It will help determine if family therapy sessions help patients and their families communicate and support each other during palliative care and after the patient's death.

Who is the study for?
This trial is for families with a member facing advanced cancer. Eligible participants include those with satisfactory cognitive function to consent and participate in therapy, at least two family members willing to join, and certain scores on a family relationship index. Families must speak English and be geographically able to attend sessions. Children under 12 or individuals with significant psychiatric issues are excluded.
What is being tested?
The study tests the effectiveness of Family Focused Grief Therapy during palliative care and after death. It compares standard care against family therapy in either 6 or 10 sessions, randomly assigning patients into these groups to see which helps more with communication and support.
What are the potential side effects?
While this trial does not involve medication that could cause physical side effects, participating in grief therapy can sometimes bring emotional discomfort such as sadness or anxiety as families work through their feelings about illness and loss.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My family has at least 2 members, including me, ready to participate.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child is under 12 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
10 Sessions of Family Focused Group Therapy
Group II: 1Experimental Treatment1 Intervention
6 sessions of Family Focused Group Therapy
Group III: 3Active Control1 Intervention
Standard Care- Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,969 Previous Clinical Trials
596,551 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,924 Previous Clinical Trials
41,017,251 Total Patients Enrolled
Beth Israel Medical CenterOTHER
70 Previous Clinical Trials
7,750 Total Patients Enrolled

Media Library

Family Focused Group Therapy Clinical Trial Eligibility Overview. Trial Name: NCT00580515 — N/A
Cancer Clinical Trial 2023: Family Focused Group Therapy Highlights & Side Effects. Trial Name: NCT00580515 — N/A
Family Focused Group Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT00580515 — N/A
Cancer Research Study Groups: 3, 1, 2
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top